Cargando…

Herpes simplex virus type 1 and type 2 in the Netherlands: seroprevalence, risk factors and changes during a 12-year period

BACKGROUND: Genital herpes results in considerable morbidity, including risk of neonatal herpes, and is increasingly being caused by Herpes Simplex Virus (HSV) type 1. Possibly children are less often HSV-1 infected, leaving them susceptible until sexual debut. We assessed changes in the Dutch HSV-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Woestenberg, Petra J., Tjhie, Jeroen H. T., de Melker, Hester E., van der Klis, Fiona R. M., van Bergen, Jan E. A. M, van der Sande, Marianne A. B., van Benthem, Birgit H. B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971663/
https://www.ncbi.nlm.nih.gov/pubmed/27484304
http://dx.doi.org/10.1186/s12879-016-1707-8
_version_ 1782446144172851200
author Woestenberg, Petra J.
Tjhie, Jeroen H. T.
de Melker, Hester E.
van der Klis, Fiona R. M.
van Bergen, Jan E. A. M
van der Sande, Marianne A. B.
van Benthem, Birgit H. B.
author_facet Woestenberg, Petra J.
Tjhie, Jeroen H. T.
de Melker, Hester E.
van der Klis, Fiona R. M.
van Bergen, Jan E. A. M
van der Sande, Marianne A. B.
van Benthem, Birgit H. B.
author_sort Woestenberg, Petra J.
collection PubMed
description BACKGROUND: Genital herpes results in considerable morbidity, including risk of neonatal herpes, and is increasingly being caused by Herpes Simplex Virus (HSV) type 1. Possibly children are less often HSV-1 infected, leaving them susceptible until sexual debut. We assessed changes in the Dutch HSV-1 and HSV-2 seroprevalence over time and determinants associated with HSV seropositivity. METHODS: We used data from two population-based seroepidemiological studies conducted in 1995–6 and 2006–7 with a similar study design. Serum samples of 6 months to 44-year-old participants were tested for type-specific HSV antibodies using HerpesSelect® with a cut-off level of >1.10 for seropositivity. Age and sex-specific HSV-1 and HSV-2 seroprevalence was weighted for the Dutch population. Logistic regression was performed to investigate determinants associated with HSV seropositivity. RESULTS: Overall, weighted HSV-1 seroprevalence was significantly lower in 2006–7 [42.7 % 95 % confidence interval (CI) 39.9-45.4] than in 1995–6 (47.7 % 95 % CI 44.8-50.7), especially among 10- to 14-year-olds. Overall, weighted HSV-2 seroprevalence remained stable: 6.8 % in 1995–6 and 6.0 % in 2006–7. Adults who ever had sexual intercourse were more often seropositive for HSV-1 [adjusted Odds Ratio (aOR) 1.69 95 % CI 1.33-2.16] and HSV-2 (aOR 2.35 95 % CI 1.23-4.52). Age at sexual debut was the only sexual risk determinant associated with HSV-1 seropositivity. CONCLUSIONS: Because of the lower HSV-1 seroprevalence in 2006–7 compared to 1995–6, more adults are susceptible to genital HSV-1, including women of reproductive age. Given the higher risk of neonatal herpes when HSV is acquired during pregnancy, prevention and control measures during pregnancy also targeting HSV-1, are important. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12879-016-1707-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4971663
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49716632016-08-11 Herpes simplex virus type 1 and type 2 in the Netherlands: seroprevalence, risk factors and changes during a 12-year period Woestenberg, Petra J. Tjhie, Jeroen H. T. de Melker, Hester E. van der Klis, Fiona R. M. van Bergen, Jan E. A. M van der Sande, Marianne A. B. van Benthem, Birgit H. B. BMC Infect Dis Research Article BACKGROUND: Genital herpes results in considerable morbidity, including risk of neonatal herpes, and is increasingly being caused by Herpes Simplex Virus (HSV) type 1. Possibly children are less often HSV-1 infected, leaving them susceptible until sexual debut. We assessed changes in the Dutch HSV-1 and HSV-2 seroprevalence over time and determinants associated with HSV seropositivity. METHODS: We used data from two population-based seroepidemiological studies conducted in 1995–6 and 2006–7 with a similar study design. Serum samples of 6 months to 44-year-old participants were tested for type-specific HSV antibodies using HerpesSelect® with a cut-off level of >1.10 for seropositivity. Age and sex-specific HSV-1 and HSV-2 seroprevalence was weighted for the Dutch population. Logistic regression was performed to investigate determinants associated with HSV seropositivity. RESULTS: Overall, weighted HSV-1 seroprevalence was significantly lower in 2006–7 [42.7 % 95 % confidence interval (CI) 39.9-45.4] than in 1995–6 (47.7 % 95 % CI 44.8-50.7), especially among 10- to 14-year-olds. Overall, weighted HSV-2 seroprevalence remained stable: 6.8 % in 1995–6 and 6.0 % in 2006–7. Adults who ever had sexual intercourse were more often seropositive for HSV-1 [adjusted Odds Ratio (aOR) 1.69 95 % CI 1.33-2.16] and HSV-2 (aOR 2.35 95 % CI 1.23-4.52). Age at sexual debut was the only sexual risk determinant associated with HSV-1 seropositivity. CONCLUSIONS: Because of the lower HSV-1 seroprevalence in 2006–7 compared to 1995–6, more adults are susceptible to genital HSV-1, including women of reproductive age. Given the higher risk of neonatal herpes when HSV is acquired during pregnancy, prevention and control measures during pregnancy also targeting HSV-1, are important. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12879-016-1707-8) contains supplementary material, which is available to authorized users. BioMed Central 2016-08-02 /pmc/articles/PMC4971663/ /pubmed/27484304 http://dx.doi.org/10.1186/s12879-016-1707-8 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Woestenberg, Petra J.
Tjhie, Jeroen H. T.
de Melker, Hester E.
van der Klis, Fiona R. M.
van Bergen, Jan E. A. M
van der Sande, Marianne A. B.
van Benthem, Birgit H. B.
Herpes simplex virus type 1 and type 2 in the Netherlands: seroprevalence, risk factors and changes during a 12-year period
title Herpes simplex virus type 1 and type 2 in the Netherlands: seroprevalence, risk factors and changes during a 12-year period
title_full Herpes simplex virus type 1 and type 2 in the Netherlands: seroprevalence, risk factors and changes during a 12-year period
title_fullStr Herpes simplex virus type 1 and type 2 in the Netherlands: seroprevalence, risk factors and changes during a 12-year period
title_full_unstemmed Herpes simplex virus type 1 and type 2 in the Netherlands: seroprevalence, risk factors and changes during a 12-year period
title_short Herpes simplex virus type 1 and type 2 in the Netherlands: seroprevalence, risk factors and changes during a 12-year period
title_sort herpes simplex virus type 1 and type 2 in the netherlands: seroprevalence, risk factors and changes during a 12-year period
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971663/
https://www.ncbi.nlm.nih.gov/pubmed/27484304
http://dx.doi.org/10.1186/s12879-016-1707-8
work_keys_str_mv AT woestenbergpetraj herpessimplexvirustype1andtype2inthenetherlandsseroprevalenceriskfactorsandchangesduringa12yearperiod
AT tjhiejeroenht herpessimplexvirustype1andtype2inthenetherlandsseroprevalenceriskfactorsandchangesduringa12yearperiod
AT demelkerhestere herpessimplexvirustype1andtype2inthenetherlandsseroprevalenceriskfactorsandchangesduringa12yearperiod
AT vanderklisfionarm herpessimplexvirustype1andtype2inthenetherlandsseroprevalenceriskfactorsandchangesduringa12yearperiod
AT vanbergenjaneam herpessimplexvirustype1andtype2inthenetherlandsseroprevalenceriskfactorsandchangesduringa12yearperiod
AT vandersandemarianneab herpessimplexvirustype1andtype2inthenetherlandsseroprevalenceriskfactorsandchangesduringa12yearperiod
AT vanbenthembirgithb herpessimplexvirustype1andtype2inthenetherlandsseroprevalenceriskfactorsandchangesduringa12yearperiod